PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 17 filers reported holding PHIO PHARMACEUTICALS CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cetera Investment Advisers | 75,000 | $43,000 | 0.00% |
| Virtu Financial LLC | 19,464 | $11,000 | 0.00% |
| VANGUARD GROUP INC | 218,192 | $125,000 | 0.00% |
| Ergoteles LLC | 12,471 | $7,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 23,198 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 91 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 107,192 | $61,000 | 0.00% |
| BALYASNY ASSET MANAGEMENT L.P. | 10,036 | $6,000 | 0.00% |
| MORGAN STANLEY | 1,502 | $1,000 | 0.00% |